Cargando…
Considerations for using distributed research networks to conduct aspects of randomized trials
Stakeholders in the clinical research enterprise are aligned around the need to make clinical research in general, and randomized controlled trials in particular, more meaningful and efficient. To that end, we have built distributed research networks (DRNs) for the Sentinel System, the National Inst...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961060/ https://www.ncbi.nlm.nih.gov/pubmed/31956724 http://dx.doi.org/10.1016/j.conctc.2019.100515 |
_version_ | 1783487913308192768 |
---|---|
author | Marsolo, Keith A. Brown, Jeffrey S. Hernandez, Adrian F. Hammill, Bradley G. Raman, Sudha R. Syat, Beth Platt, Richard Curtis, Lesley H. |
author_facet | Marsolo, Keith A. Brown, Jeffrey S. Hernandez, Adrian F. Hammill, Bradley G. Raman, Sudha R. Syat, Beth Platt, Richard Curtis, Lesley H. |
author_sort | Marsolo, Keith A. |
collection | PubMed |
description | Stakeholders in the clinical research enterprise are aligned around the need to make clinical research in general, and randomized controlled trials in particular, more meaningful and efficient. To that end, we have built distributed research networks (DRNs) for the Sentinel System, the National Institutes of Health (NIH) Collaboratory, and the National Patient-Centered Clinical Research Network (PCORnet). DRNs reuse electronic health record (EHR) and claims data for research. The design and use of health data DRNs is complicated by lack of uniformity in data collection, a fragmented healthcare system, and the imperative to protect research participants. We describe the key elements of successful DRNs, as well as methods, challenges, and solutions we have encountered in using DRNs to support different phases of randomized, multi-site, clinical research. This work supports “real-world” efforts to build a learning health system and will enable others to conduct randomized clinical trial research using a DRN. |
format | Online Article Text |
id | pubmed-6961060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-69610602020-01-17 Considerations for using distributed research networks to conduct aspects of randomized trials Marsolo, Keith A. Brown, Jeffrey S. Hernandez, Adrian F. Hammill, Bradley G. Raman, Sudha R. Syat, Beth Platt, Richard Curtis, Lesley H. Contemp Clin Trials Commun Article Stakeholders in the clinical research enterprise are aligned around the need to make clinical research in general, and randomized controlled trials in particular, more meaningful and efficient. To that end, we have built distributed research networks (DRNs) for the Sentinel System, the National Institutes of Health (NIH) Collaboratory, and the National Patient-Centered Clinical Research Network (PCORnet). DRNs reuse electronic health record (EHR) and claims data for research. The design and use of health data DRNs is complicated by lack of uniformity in data collection, a fragmented healthcare system, and the imperative to protect research participants. We describe the key elements of successful DRNs, as well as methods, challenges, and solutions we have encountered in using DRNs to support different phases of randomized, multi-site, clinical research. This work supports “real-world” efforts to build a learning health system and will enable others to conduct randomized clinical trial research using a DRN. Elsevier 2020-01-02 /pmc/articles/PMC6961060/ /pubmed/31956724 http://dx.doi.org/10.1016/j.conctc.2019.100515 Text en © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Marsolo, Keith A. Brown, Jeffrey S. Hernandez, Adrian F. Hammill, Bradley G. Raman, Sudha R. Syat, Beth Platt, Richard Curtis, Lesley H. Considerations for using distributed research networks to conduct aspects of randomized trials |
title | Considerations for using distributed research networks to conduct aspects of randomized trials |
title_full | Considerations for using distributed research networks to conduct aspects of randomized trials |
title_fullStr | Considerations for using distributed research networks to conduct aspects of randomized trials |
title_full_unstemmed | Considerations for using distributed research networks to conduct aspects of randomized trials |
title_short | Considerations for using distributed research networks to conduct aspects of randomized trials |
title_sort | considerations for using distributed research networks to conduct aspects of randomized trials |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961060/ https://www.ncbi.nlm.nih.gov/pubmed/31956724 http://dx.doi.org/10.1016/j.conctc.2019.100515 |
work_keys_str_mv | AT marsolokeitha considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials AT brownjeffreys considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials AT hernandezadrianf considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials AT hammillbradleyg considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials AT ramansudhar considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials AT syatbeth considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials AT plattrichard considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials AT curtislesleyh considerationsforusingdistributedresearchnetworkstoconductaspectsofrandomizedtrials |